NCT06704321View on ClinicalTrials.gov

Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

TOTUM-448

16 weeks of TOTUM-448 supplementation (4.284g/day corresponding to 8 capsules per day)

DIETARY_SUPPLEMENT

Placebo

16 weeks of placebo supplementation (8 capsules per day)

Trial Locations (1)

G1V 0A6

RECRUITING

Institut sur la nutrition et les aliments fonctionnels (INAF), Québec

All Listed Sponsors
collaborator

CHU de Quebec-Universite Laval

OTHER

collaborator

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

OTHER

collaborator

Laval University

OTHER

collaborator

Valbiotis Canada inc.

UNKNOWN

lead

Valbiotis

INDUSTRY